Larvol Delta - Attralus-and-Ossianix-Announce-an-Option-and-License-Agreement-using-the-TXP1-Brain-Shuttle-for-Targeted-Delivery-of-AT04-a-PanAmyloid-Removal-Therapeutic-for-Neurodegenerative-Disorders

AT-04 - Attralus

https://www.globenewswire.com/news-release/2022/11/17/2558010/0/en/Attralus-and-Ossianix-Announce-an-Option-and-License-Agreement-using-the-TXP1-Brain-Shuttle-for-Targeted-Delivery-of-AT-04-a-Pan-Amyloid-Removal-Therapeutic-for-Neurodegenerative-D.html

Nov 17, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next